Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
BrainsWay Ltd. stock logo
BWAY
BrainsWay
$4.95
+4.2%
$5.82
$1.38
$7.61
$82.37M1.2120,837 shs11,449 shs
LENSAR, Inc. stock logo
LNSR
LENSAR
$3.14
-3.4%
$3.91
$1.80
$5.30
$35.80M0.4740,011 shs8,717 shs
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$0.56
+5.5%
$0.50
$0.26
$1.14
$19.60M1.5832,469 shs2,579 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
BrainsWay Ltd. stock logo
BWAY
BrainsWay
-2.67%-10.06%-18.42%-18.97%+200.00%
LENSAR, Inc. stock logo
LNSR
LENSAR
+0.62%+3.17%-7.41%0.00%+23.11%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
-2.75%+13.98%+6.43%+2.71%-53.10%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
BrainsWay Ltd. stock logo
BWAY
BrainsWay
2.4909 of 5 stars
3.35.00.00.02.30.80.6
LENSAR, Inc. stock logo
LNSR
LENSAR
2.2227 of 5 stars
3.53.00.00.02.62.50.0
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
0.9154 of 5 stars
2.03.00.00.02.61.70.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
BrainsWay Ltd. stock logo
BWAY
BrainsWay
2.67
Moderate Buy$7.0041.41% Upside
LENSAR, Inc. stock logo
LNSR
LENSAR
3.00
Buy$8.00154.78% Upside
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/AN/A$3.80579.91% Upside

Current Analyst Ratings

Latest SSKN, BWAY, and LNSR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/19/2024
LENSAR, Inc. stock logo
LNSR
LENSAR
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy$8.00
3/11/2024
BrainsWay Ltd. stock logo
BWAY
BrainsWay
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
BrainsWay Ltd. stock logo
BWAY
BrainsWay
$31.78M2.59N/AN/A$2.50 per share1.98
LENSAR, Inc. stock logo
LNSR
LENSAR
$42.16M0.85N/AN/A$2.97 per share1.06
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
$33.36M0.59N/AN/A$0.37 per share1.51

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
BrainsWay Ltd. stock logo
BWAY
BrainsWay
-$4.20M-$0.13N/A61.88N/A-13.20%-10.05%-6.88%5/15/2024 (Estimated)
LENSAR, Inc. stock logo
LNSR
LENSAR
-$14.38M-$1.79N/AN/A-34.11%-40.53%-21.83%5/20/2024 (Estimated)
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
-$10.83M-$0.31N/AN/AN/A-32.47%-52.50%-17.66%5/20/2024 (Estimated)

Latest SSKN, BWAY, and LNSR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/27/2024Q4 2023
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/A-$0.04-$0.04$0.03N/A$8.69 million
3/6/202412/31/2023
BrainsWay Ltd. stock logo
BWAY
BrainsWay
-$0.03-$0.01+$0.02N/A$8.40 million$9.03 million    
3/4/202412/31/2023
LENSAR, Inc. stock logo
LNSR
LENSAR
-$0.22-$0.22N/A-$0.35N/A$12.11 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
BrainsWay Ltd. stock logo
BWAY
BrainsWay
N/AN/AN/AN/AN/A
LENSAR, Inc. stock logo
LNSR
LENSAR
N/AN/AN/AN/AN/A
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
BrainsWay Ltd. stock logo
BWAY
BrainsWay
N/A
5.68
5.30
LENSAR, Inc. stock logo
LNSR
LENSAR
N/A
3.99
2.64
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
1.19
1.28
1.06

Ownership

Institutional Ownership

CompanyInstitutional Ownership
BrainsWay Ltd. stock logo
BWAY
BrainsWay
30.11%
LENSAR, Inc. stock logo
LNSR
LENSAR
40.15%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
32.43%

Insider Ownership

CompanyInsider Ownership
BrainsWay Ltd. stock logo
BWAY
BrainsWay
19.00%
LENSAR, Inc. stock logo
LNSR
LENSAR
66.00%
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
40.43%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
BrainsWay Ltd. stock logo
BWAY
BrainsWay
13416.64 million13.48 millionNot Optionable
LENSAR, Inc. stock logo
LNSR
LENSAR
13011.40 million3.87 millionOptionable
STRATA Skin Sciences, Inc. stock logo
SSKN
STRATA Skin Sciences
9935.06 million20.89 millionNot Optionable

SSKN, BWAY, and LNSR Headlines

SourceHeadline
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
globenewswire.com - April 23 at 8:30 AM
STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52STRATA Skin Sciences (NASDAQ:SSKN) Share Price Crosses Above 200 Day Moving Average of $0.52
americanbankingnews.com - April 23 at 3:20 AM
STRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11STRATA Skin Sciences (SSKN) Price Target Increased by 32.61% to 3.11
msn.com - April 18 at 12:46 AM
STRATA Skin Sciences (NASDAQ:SSKN) Share Price Passes Above Two Hundred Day Moving Average of $0.52STRATA Skin Sciences (NASDAQ:SSKN) Share Price Passes Above Two Hundred Day Moving Average of $0.52
americanbankingnews.com - April 13 at 2:40 AM
STRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in AsiaSTRATA Skin Sciences Bolsters International Presence with Renewed Distribution Agreements in Asia
msn.com - April 10 at 7:44 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
finanznachrichten.de - April 9 at 2:16 PM
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and JapanSTRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
globenewswire.com - April 9 at 8:30 AM
STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2023 Earnings Call TranscriptSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q4 2023 Earnings Call Transcript
finance.yahoo.com - April 1 at 7:34 PM
STRATA Skin Sciences Unveils 2023 Financial Results: A Look into an Evolving Business ModelSTRATA Skin Sciences Unveils 2023 Financial Results: A Look into an Evolving Business Model
msn.com - March 31 at 6:32 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
finanznachrichten.de - March 29 at 3:08 PM
Earnings Preview For Strata Skin SciencesEarnings Preview For Strata Skin Sciences
benzinga.com - March 28 at 10:35 PM
Q4 2023 STRATA Skin Sciences Inc Earnings CallQ4 2023 STRATA Skin Sciences Inc Earnings Call
finance.yahoo.com - March 28 at 8:26 AM
Recap: Strata Skin Sciences Q4 EarningsRecap: Strata Skin Sciences Q4 Earnings
benzinga.com - March 27 at 5:25 PM
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 EarningsSTRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
globenewswire.com - March 27 at 4:01 PM
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
globenewswire.com - March 13 at 8:00 AM
Spearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin TreatmentsSpearheading Change in Dermatology: STRATA Pushes for Expanded Insurance Coverage of Vital Skin Treatments
msn.com - March 11 at 6:59 PM
STRATA Skin Sciences Announces Initiative to Expand Treatment CoverageSTRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
globenewswire.com - March 7 at 8:00 AM
SSKN STRATA Skin Sciences, Inc.SSKN STRATA Skin Sciences, Inc.
seekingalpha.com - March 3 at 12:43 PM
STRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic InitiativesSTRATA Skin Sciences Successfully Amends Credit Agreement, Bolstering Strategic Initiatives
msn.com - February 29 at 2:54 PM
STRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialSTRATA Skin Sciences, Inc.: STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
finanznachrichten.de - February 27 at 10:35 AM
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap FinancialSTRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
globenewswire.com - February 26 at 4:01 PM
Strata Skin Sciences Inc SSKNStrata Skin Sciences Inc SSKN
morningstar.com - February 22 at 7:35 AM
STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?STRATA Skin Sciences, Inc. (NASDAQ:SSKN): Are Analysts Optimistic?
finance.yahoo.com - January 11 at 10:36 AM
STRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 ConferenceSTRATA Skin Sciences to Present Poster Showcasing Safety and Efficacy of TheraClear®X for Acne at Maui Derm 2024 Conference
finance.yahoo.com - January 8 at 8:23 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

BrainsWay logo

BrainsWay

NASDAQ:BWAY
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.
LENSAR logo

LENSAR

NASDAQ:LNSR
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company also offers ALLY Adaptive Cataract Treatment System, a platform design to femtosecond laser technology features that enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
STRATA Skin Sciences logo

STRATA Skin Sciences

NASDAQ:SSKN
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.